Subscribe to Newsletter

Sartorius Stedim Biotech

Sartorius’ roots go all the way back to the 1870s when Florenz Sartorius founded "Feinmechanische Werkstatt F. Sartorius” in Goettingen, Germany. Although initially starting out as a company specialized in weighing and balance equipment, Sartorius has evolved over the last 150 years to become an important partner for the biopharmaceutical and life science industries.

The company has grown its products and services through acquisitions as well as organic growth and internal innovation. The Stedim acquisition about a decade ago brought single use bags and film technology to the company’s portfolio. Today, the company has a full suite of scalable products for upstream bioprocessing. Most recently, Sartorius expanded its downstream portfolio. For chromatography solutions in particular, with products acquired from Danaher, BIA Separations and most recently Novasep, Sartorius has solutions to assist with emerging modalities, such as mRNA, pDNA and AAV, as well as mAbs and traditional vaccines.

At the company’s annual general shareholders’ meeting in March 2022, the company said that group sales revenue in 2021 increased by almost 50 percent compared with 2020, with growth in the lab products & services division, as well as the bioprocess solutions division. The company is currently focusing on expanding its global footprint to better serve its customers, with the goal of doubling capacity for key product groups by 2025.


Global headquarters: Goettingen, Germany

Number of employees: Approx. 14,000

Annual sales revenue in fiscal 2021: 3.45 billion euros

Global Footprint:60 sites in more than 30 countries

Other recent news:

Sartorius acquires majority stake in ALS Automated Lab Solutions

Company completes acquisition of Novasep’s chromatography division

Sartorius grows operations in France and is investing 100 million euros by 2025

Honorable mention: Danaher

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine